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ABSTRACT
Mutations in SOX10 cause neurocristopathies which
display varying degrees of hypopigmentation. Us-
ing a sensitized mutagenesis screen, we identified
Smarca4 as a modifier gene that exacerbates the
phenotypic severity of Sox10 haplo-insufficient mice.
Conditional deletion of Smarca4 in SOX10 express-
ing cells resulted in reduced numbers of cranial and
ventral trunk melanoblasts. To define the require-
ment for the Smarca4 -encoded BRG1 subunit of
the SWI/SNF chromatin remodeling complex, we em-
ployed in vitro models of melanocyte differentiation
in which induction of melanocyte-specific gene ex-
pression is closely linked to chromatin alterations.
We found that BRG1 was required for expression
of Dct, Tyrp1 and Tyr, genes that are regulated by
SOX10 and MITF and for chromatin remodeling at dis-
tal and proximal regulatory sites. SOX10 was found
to physically interact with BRG1 in differentiating
melanocytes and binding of SOX10 to the Tyrp1 dis-
tal enhancer temporally coincided with recruitment
of BRG1. Our data show that SOX10 cooperates with
MITF to facilitate BRG1 binding to distal enhancers of
melanocyte-specific genes. Thus, BRG1 is a SOX10
co-activator, required to establish the melanocyte lin-
eage and promote expression of genes important for
melanocyte function.
INTRODUCTION
Neurocristopathies are a diverse set of genetic disorders that
involve defects in cells derived from the embryonic neural
crest (1). Waardenburg syndrome (WS) is a type of neu-
rocristopathy primarily caused by melanocyte deficiencies
andmanifested by varying degrees of skin and hair hypopig-
mentation, pigmentation defects of the choroid and iris, and
deafness from loss of inner ear melanocytes. There are four
clinically distinct WS types that are due to mutations in dif-
ferent genes (2–6): WS1 and WS3 result from mutations
in the PAX3 gene, some cases of WS2 are due to muta-
tions in theMicrophthalmia-associated transcription factor
(MITF) gene and some cases of WS2 and WS4 are due to
haploinsufficiency of SOX10, which can also result in agan-
glionosis of the distal colon, and peripheral neuropathies.
Individuals with SOX10 haploinsufficiency display pheno-
typic variability, suggesting the existence of additionalmod-
ifier genes.
SOX10 is a member of the SOX (Sry-related high-
mobility-group box) family of transcription factors that is
essential for neural crest stem cell survival and for differenti-
ation into melanocytes and Schwann cells (7). Members of
this family generally cooperate with other transcriptional
regulators to synergistically activate transcription, binding
to AT-rich motifs in the minor groove of DNA (8). During
Schwann cell differentiation, SOX10 interacts with a differ-
ent set of transcription factors to activate genes required
for myelination (9–13). SOX10 has been shown to interact
with the SWI/SNF chromatin remodeling complex and to
recruit the complex to Schwann cell-specific loci (14,15).
SWI/SNF chromatin remodeling enzymes utilize energy
from ATP hydrolysis to physically remodel chromatin and
regulate gene expression (16). At the core of the complex is
either of two ATPases, BRG1 or BRM, which are encoded
by the Smarca4 and Smarca2 genes, respectively. BRG1 and
BRM each have a conserved ATPase domain that utilizes
the energy fromATP hydrolysis to alter DNA-histone inter-
actions, rendering sites accessible to factor binding and in
some cases promoting nucleosome repositioning or eviction
(17–19). Distinct SWI/SNF complexes containing BRG1
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or BRM are formed through associations with 9–11 addi-
tional subunits known as BRG1/BRM-associated factors
(BAFs) (20). SWI/SNF enzymes lack sequence specificity
and are thought to be recruited to target regions primar-
ily by interactions with major transcriptional regulators
such as C/EBP factors in myeloid cells and adipocytes (21–
23), MYOD in muscle (24,25), NEUROD in neurons (26),
SOX10 in Schwann cells (14,15) and MITF in melanocytes
(27–29). SWI/SNF enzymes play essential roles in main-
taining embryonic pluripotency as well as promoting lin-
eage specification and differentiation (30). Disruption of
Smarca4 causes early embryonic lethality (31). Mice with
melanocyte-specific disruption of Smarca4 fail to develop
melanocytes and thus lack pigmentation (29). Schwann
cell-specific disruption of Smarca4 severely compromises
Schwann cell differentiation and causes peripheral neu-
ropathy (14). Thus, Smarca4-encoded BRG1 is critically re-
quired for the development of two neural crest cell-derived
lineages, which are both also highly dependent on SOX10.
It has been well established that BRG1 interacts withMITF
and co-activates MITF target genes in melanocytes and
melanoma cells. BRG1 is a SOX10 co-activator in Schwann
cells, however it remains to be determined if BRG1 also
interacts with SOX10 to regulate melanocyte development
and function.
In this study, we employed a previously established N-
ethyl-N-nitrosourea (ENU) mutagenesis screen and identi-
fied Smarca4 as a modifier gene that exacerbates the phe-
notypic severity of SOX10LacZ/+ mice (32). We confirmed
that the Smarca4mutation was responsible for the pigmen-
tation phenotype by deleting Smarca4 in SOX10-expressing
cells. To mechanistically define the functional interaction
between SOX10 and BRG1 in the regulation of genes that
promote melanocyte function, we utilized in vitro models
of melanocyte differentiation and characterized chromatin
structural changes at the regulatory regions of melanocyte-
specific genes that are induced during differentiation. We
found that BRG1 is required for melanocyte differentiation,
expression of melanocyte-specific genes, and chromatin re-
modeling at regulatory sites on SOX10 and MITF target
genes. SOX10 was found to interact with BRG1 and to
cooperate with MITF in recruiting BRG1 to melanocyte-
specific regulatory regions.
MATERIALS AND METHODS
Mouse genetics and husbandry
Maintenance of the Sox10LacZ line (SOX10tm1Weg) was
performed as previously described (32). SOX10LacZ and
Smarca4Mos6 mice were bred and housed in an NHGRI an-
imal facility according to NIH guidelines. Animal care was
done in accordance with NHGRI institutional standards
andwas approved by the Institutional Animal Care andUse
Committee,NHGRI, andNIH Institutional ReviewBoard.
Mice carrying the Tg(SOX10-cre)1Wdr transgene (33) and a
floxed BRG1 allele, Smarca4tm1.2Pcn (34) were bred in the
Erlangen animal facility in accord with EU animal welfare
laws with approval of the responsible local committees and
government bodies.
Mapping and exome sequencing of the Smarca4 Mos6 muta-
tion
A low density genome scan was completed with seven af-
fected mice using 61 SSLP markers (a subset of MIT mark-
ers described in (35) polymorphic between the founder
strainsC57BL/6J andBALBcJ). Because of amixed genetic
background of the founder mouse, a portion of the genome
was not informative in this initial mapping. Following this
preliminary genome scan, 11 regions were identified as ‘po-
tentially linked’ (two regions of linkage plus an additional
nine uninformative regions). One sample from an affected
mouse was used for exome sequencing. Sequence variants
were filtered to remove low quality variants, variants not
predicted to alter coding sequences, variants present in db-
SNP, and variants previously identified in other exome se-
quencing projects of independent mutants on the same ge-
netic background within our laboratory. After filtering, 69
variants remained within the 11 regions of ‘potential link-
age’. These variants included two on Chr 9, both within
Smarca4. Subsequent breeding confirmed segregation of
the Smarca4 variants with the Mos6 phenotype in 42 mice
across three generations.
Genotyping
The Taqman assay or RT-PCR was used for genotyping.
In situ hybridization, immunohistochemistry and -
galactosidase staining
Whole mount in situ hybridization was performed essen-
tially as described (36). Embryos underwent overnight fix-
ation in 4% paraformaldehyde at 4◦C. After dehydration,
bleaching and rehydration, in situ hybridization was per-
formed with DIG-labeled antisense riboprobes for Kit, Dct
and MITF. All steps except probe hybridization and final
colorimetric detection were performed on a Biolane HTI
(Ho¨lle & Hu¨ttner AG, Tu¨bingen, Germany).
Immunohistochemistry was performed on 10-m-thick
sections from the trunk of embryos after fixation, embed-
ding, freezing and cryotome sectioning using the following
primary antibodies: anti-Islet1 mouse monoclonal (1:500
dilution, Developmental Studies Hybridoma Bank), anti-
MITF rabbit antiserum (1:1000 dilution, gift of H. Arn-
heiter, NIH, Bethesda, MD, USA), anti-FABP7 rabbit an-
tiserum (1:300 dilution; Millipore), anti-SOX10 guinea pig
antiserum [1:1000 dilution (37)]. Secondary antibodies con-
jugated to Cy2, Cy3 (1:200 dilution, Dianova) or Alexa488
(1:500 dilution, Molecular Probes/Invitrogen) immunoflu-
orescent dyes were used for detection. Nuclei were counter-
stained with 4′,6-diamidin-2-phenylindole (DAPI).
-Galactosidase (-gal) staining was performed on
whole embryos as previously described (32).
Cell culture and expression plasmids
MITF-M and SOX10 retroviral plasmids were described in
(15,27). B22 cells were cultured as described in (38). Melb-
a cells were obtained from the Wellcome Trust Functional
Genomics Cell Bank (St. George’s, University of London,
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UK) and cultured in growth medium (RPMI 1640 with
10% fetal bovine serum, 40 pM fibroblast growth factor
and 10 ng/ml stem cell factor) at 37◦C under 5% CO2.
Differentiation was induced when cultures were 70% con-
fluent by replacing growth medium with differentiation
medium (DMEM with 10% fetal bovine serum, 2 nM al-
pha melanocyte stimulating hormone (NDP-alpha MSH)
and 200 nM phorbol–myristate–acetate (39). C2C12 and
3T3L1 cells were from the American Type Culture Collec-
tion (ATCC) and cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum.
RNA isolation and quantitative PCR (qPCR)
Total RNA was isolated using Trizol (Life Technolo-
gies, Carlsbad, CA, USA) and cDNA was prepared
using the Quantitect Reverse Transcription kit (Qia-
gen, Valencia, CA, USA). Quantitative PCR (qPCR)
was performed in SYBR Green master mix (Qia-
gen) and analyzed as described (28). Primers used for
mouse Dct: 5′-GGACCGGCCCCGACTGTAATC-3′
and 5′-GGGCAACGCAAAGGACTCAT-3′, mouse
Tyrp1: 5′-GCCCCAACTCTGTCTTTTCTCAAT-
3′ and 5′-GATCGGCGTTATACCTCCTTAGC-
3′, mouse Tyrosinase (Tyr: 5′-
CGGCCCAAATTGTACAGAGAAGC-3′ and 5′-
CTGCCAGGAGAAGAAGGATTG-3′, mouse
Trpm1: 5′-CCTACGACACCAAGCCAGAT-3′, and
5′-GACGACACCAGTGCTCACAC-3′, and mouse
Rab27a: 5′-CGACCTGACAAATGAGCAAA-3′ and 5′-
GGCAGCACTGGTTTCAAAAT-3′. Mouse Mpz, Mbp,
and Rpl7 primers were described in (15).
Cell extracts and immunoblot analysis
Total cell extracts were prepared and Western blots were
performed as described (28). Antiserum toBRG1was previ-
ously described (38). The BRM andMITF antibodies were
from Abcam (Cambridge, MA, USA), the SOX10 anti-
bodywas from Santa Cruz Biotechnology (Santa Cruz, CA,
USA), the FLAGantibodywas from Sigma (St. Louis,MO,
USA), BAF60A and BAF60B antibodies were from Bethyl
Laboratories (Montgomery, TX, USA) and the Tubulin an-
tibody was from Cell Signaling Technology (Boston, MA,
USA).
Melanin assays
Cells were analyzed formelanin content as described in (40).
Briefly, cells were trypsinized and counted using the Scepter
2.0 handheld automated cell counter (Millipore) Cells were
lysed in 0.1 M NaOH and vortexed for 20 min. Melanin
content was calculated based on the absorbance at 475 nm
as compared to the standard curve obtained using synthetic
melanin (Sigma, St. Louis, MO, USA) and normalized to
cell number.
siRNA knockdown
A non-targeting siRNA and siRNA targeting MITF as
reported in (41–44), siRNA targeting rodent SOX10 as re-
ported in (15,45), siBRG1/BRM as reported in (28,46) and
a SMART pool of siRNAs targeting BRG1 (siBRG1-D)
were obtained fromDharmacon Inc. (Lafayette, CO,USA).
Two additional siRNAs that target mouse BRG1 (siBRG1-
II3.1: 5′-GUCAGACAGUAAUAAAUUAAAGCAA-3′
and siBRG1-I13.3:5′-GAUGAUGAGACCGUCAACCA
GAUGA-3′) and siRNAs that target mouse BRM (siBRM-
I13.2: 5′-AUCAUUGAUACUGUGAUAAACUACA-3′
and siBRM-I13.3: 5′-GAUGUGGGUGGAUAGUAU
AUUUCTA-3′) were purchased from Integrated DNA
Technologies (Coralville, IA, USA). siRNas were trans-
fected with Dharmafect 1 according to manufacturer’s
instructions. Undifferentiated Melb-a cells were trans-
fected in growth medium for 48 h and harvested or the
medium was then replaced and the cells were cultured in
differentiation medium for an additional 48 h.
Formaldehyde-assisted Isolation of regulatory elements
(FAIRE)
FAIRE was performed as essentially as described in (47).
Cells were crosslinked in 1% formaldehyde for 6 min at
room temperature and quenched with 125 mM glycine.
Cells were then lysed using the buffers listed in the alter-
native lysis method as described in (48) and sonicated as
described in (28). Sonicated chromatin was subjected to two
rounds of phenol/chloroform extractions, back extracted
once with TE and then once with chloroform. The aqueous
phase was ethanol precipitated and digested with 0.2mg/ml
Proteinase K for 1 h at 55◦C. Cross-links were then reversed
by heating overnight at 65◦C. DNA was then purified by
an additional phenol chloroform extraction and ethanol
precipitation. Control Inputs were 10% of each sample that
was heated at 65◦C overnight to reverse crosslinking prior
to purification. The primers used were: mouse Dct distal
region: 5′-ACGGTTCCACGCAAATTAAA-3′ and 5′-
TACTTCTCCCCCATGACTGC-3′, mouse Dct proximal
region: 5′-GGCGAGCCAGAGAGAATAAA-3′ A and
5′-TTCTCGCCAGTCTTCCTTGT, mouse Tyrp1 distal
region: 5′-TGACAGTGAGGGCACATTTC-3′ and 5′-
ACCCATGTTCCCAGACTGAA-3′, mouse Tyrp1 proxi-
mal region: 5′-GCAAAATCTCTTCAGCGTCTC-3′ and
5′-AGCCAGATTCCTCACACTGG-3′, mouse tyrosinase
(Tyr) distal region 5′-TGCCAGCTGACTTTGTCAAG-3′
and 5′-AATATTGTGGTTTGCCAGGA-3′, mouse Tyr
proximal: 5′-AGTCATGTGCTTTGCAGAAGAT-3′
and 5′-CAGCCAAGAACATTTTCTCCTT-3′ mouse
Scn2a1: 5′-AAGCAGCTGCCTTTGGGAAG-3′ and
CACAGGACACTGAGCATCAAG-3′ and mouse MyoD
CER as reported in (49).
Chromatin immunoprecipitation (ChIP)
ChIP was performed as described (28) using the same anti-
bodies as in Westerns as well as antibodies to histone H3,
H3K4me3 and H3K27ac that were obtained from Abcam.
Primers were the same as used in FAIRE.
Statistical analysis
Statistical significance was calculated by the Student’s t test.
One way ANOVA followed by Tukey’s post-hoc test was
used for comparing multiple groups.
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RESULTS
ENU alleles of Smarca4
We used a previously established N-ethyl-N-nitrosourea
(ENU) mutagenesis screen to identify novel modifiers of
SOX10 neurocristopathies (Mos) (32). Briefly, BALB/cJ
male mice were given weekly ENU injections for 3 weeks,
and after regaining fertility, mated with C57BL/6J females
to generate first generation (G1) offspring. G1 males were
mated with Sox10LacZ/+ females and second generation
(G2) offspring were then scored for hypopigmentation. One
of the founder mutants,Mos6, had more severe white spot-
ting than is typically observed in the Sox10LacZ/+ hap-
loinsufficient mice (Figure 1A). Further breeding of this
founder and quantitation of ventral spotting in the pedi-
gree showed that Mos6 synergistically increased the sever-
ity of white spotting observed in SOX10 haploinsufficient
mice (Figure 1B). To map the Mos6 locus, seven affected
Mos6/+; SOX10LacZ/+ double heterozygotes were geno-
typed in a low density genome scan (61 simple sequence
length polymorphism markers), and in parallel with this
linkage mapping, one Mos6/+; SOX10LacZ/+ double het-
erozygote sample was used for exome sequencing. Candi-
date sequence variants within regions of potential linkage
were further refined by subsequent breeding that confirmed
linkage of Mos6 to two sequence variants within Smarca4,
the gene that encodes BRG1.
The two Smarca4 ENU mutations include a splice site
variant at the consensus 5′ donor splice site of exon 11 (mm9
Chr9:21447196;G>T) as well as a downstream variant in
exon 22 (mm9Chr9:21474974;G>A). Subsequent genotyp-
ing of bothSmarca4ENUmutations confirmed strong link-
age with theMos6 phenotype throughout the colony (0/42
recombinants over three generations; x2 = 42; P < 0.0001).
Because of the proximity of the two ENUmutations within
Smarca4, they could not be segregated in the colony and
thus we could not determine the relative contribution of the
two mutations individually to the phenotype. However, the
splice site variant at the junction of exon 11 and intron 11
(c.1812+1G>T,NM 001174078.1) is predicted to introduce
a frameshift resulting in protein truncation upstream of the
variant in exon 22, thus rendering the exon 22 variant inca-
pable of contributing to the in vivo phenotype. To confirm
the consequence of the splice site variant, RT-PCRproducts
fromMos6 heterozygotes were sequenced. There was no ev-
idence of exon skipping or intron retention resulting from
the splice site variant, however, a mutant transcript was de-
tected that results from activation of a cryptic splice site 5 bp
upstream of the Exon 11 splice site disrupted by the muta-
tion (Figure 1C). The ratio of chromatogrampeaks detected
by sequencing of the RT-PCR product suggested that the
mutant transcript was present at low levels (∼15% of the to-
tal transcript (Figure 1C). To further characterize the stabil-
ity of thisMos6mutant transcript, the relative ratio of wild
type and mutant transcript was measured in an outcross to
FVB/N, where a strain-specific SNP (rs48515263) within
exon 15 of Smarca4 could be used to assess relative expres-
sion of the two alleles. In cDNA from a wild-type F1 hy-
brid embryo, the two SNP alleles (C57BL/6J and FVB/N)
were detected in equal proportion. In contrast, cDNA from
aMos6 heterozygous F1 hybrid embryo confirmed that the
C57BL/6J SNP allele carrying the linked Mos6 mutations
was barely detectable relative to the FVB/N wild-type al-
lele, thus indicating that the mutant transcript was unstable
(Figure 1D). Consistent with this, Western blotting failed
to detect any evidence of the truncated protein (605 aa for
Smarca4mutant versus 1617 aa for wild-type) thatmight re-
sult from any residualMos6mutant transcript (Figure 1E).
In summary, the low levels of mutant transcript along with
the negative Western data indicate that the splice site mu-
tation is likely responsible for the phenotype observed in
Mos6mice and that theMos6 allele is functionally null. We
subsequently use the allele name Smarca4Mos6 to refer to the
allele that contains both point mutations.
Because of the visible white spotting in
Smarca4Mos6/+;Sox10LacZ/+ double heterozygote adult
mice, we sought to further characterize the effect of
Smarca4 mutation on melanocyte development. A
reduction in melanoblasts was first evident at E13.5
when the number of cranial melanoblasts marked by
whole mount -gal staining was significantly reduced in
Smarca4Mos6/+;Sox10LacZ/+ double heterozygotes com-
pared to Sox10LacZ/+ heterozygotes (Supplementary Figure
S1). The reduction in melanoblast number was Sox10-
dependent, as a similar reduction was not observed in
Smarca4Mos6/+ heterozygote embryos where melanoblasts
were marked with a Dct-LacZ transgene (data not shown).
Further characterization of melanoblast development was
limited as we were not able to recover Smarca4 Mos6/Mos6
homozygous embryos at E9.5 or later time points, con-
sistent with published observations of early embryonic
lethality resulting from a Smarca4 null allele (31),
Conditional deletion of Smarca4 in melanoblasts
To further characterize the impact of Smarca4-deficiency
on melanocyte development and confirm Smarca4Mos6 as
the causative mutation for the Mos6 phenotype, we char-
acterized a second allele of Smarca4. Melanocyte develop-
ment was examined when Smarca4 was specifically deleted
in SOX10-expressing cells using a SOX10-Cre construct
(33,34). This conditional deletion of Smarca4 and sub-
sequent loss of BRG1 expression resulted in a striking
reduction in the numbers of cranial and ventral trunk
melanoblasts at E12.5 as visualized by Mitf, Dct and Kit
in situ hybridization (Figure 2A and B). Quantification of
cells in the eye region that were positive for Mitf, Dct and
Kit revealed a drastic reduction of melanocytes (Figure 2B,
region 1). Mitf-positive cells were reduced to 1.3 ± 0.7%,
Dct-posititve cells to 1.6 ± 0.4% and Kit-positive cells to
13.0 ± 8.8% (Figure 2C). Immunohistochemistry of trunk
sections indicated a less pronounced, but qualitatively simi-
lar reduction ofMitf-positive cells to 43.6± 10.6% (Supple-
mentary Figure S2). This correlates with a Sox10-Cre me-
diated deletion rate of 57 ± 5% (n = 3) that we determined
for a Rosa26-stopflox-YFP reporter in trunk melanocytes
(data not shown). We also investigated the consequences of
the Smarca4 deletion on other neural crest lineages as well
as the possibility of a fate switch in melanoblasts. However,
FABP7-expressing Schwann cell precursors along periph-
eral nerves (Supplementary Figure S3A, left) and ISLET1-
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Figure 1. Identification of the Smarca4Mos6 allele. (A) SOX10LacZ/+; Mos6/+ double heterozygous mice exhibited a head spot and extensive belly spot-
ting, demonstrating that the presence of the Mos6 allele increased the spotting phenotype of SOX10LacZ/+. (B) Hypopigmentation in the trunk of adult
mice was quantitated using a standardized scale of 0–4, in which 0 indicates no spotting, and 1–4 indicates progressively greater hypopigmentation (32).
Mos6 synergistically increased the ventral white spotting observed in SOX10 haploinsufficient mice. (C) The Smarca4 mutation splice site variant (mm9
Chr9:21447196;G>T) that alters a consensus 5′ donor splice site at the junction of exon 11 and intron 11 (c.1812+1G>T, NM 001174078.1). Low levels
of a mutant transcript were detected (15% of total transcript), suggesting the mutant causes activation of a cryptic splice site within exon 11, as illustrated.
(D) In cDNA from an outcross C57BL/6J and FVB/N F1 hybrid embryo, the two strain-specific alleles at rs48515263, a SNP located within exon 15 of
Smarca4, were present in equal proportion. In cDNA from an embryo carrying the Mos6 ENU-induced C57BL/6J mutation, the C57BL/6J SNP allele
detected in the mutant transcript was reduced relative to the FVB/N wild-type allele, consistent with instability of the Mos6 mutant allele. (E) Western
blots detected only wild-type BRG1 expressed in Mos6/+ heterozygous embryos. Similar results were observed using four embryos of each genotype run
in triplicate Western blots with no detection of a truncated protein even with overloading or overexposure.
positive sensory neurons in dorsal root ganglia (Supple-
mentary Figure S2B) are still present in the Smarca4-
deleted mice despite near complete deletion of the Rosa26–
stopflox–YFP reporter. We also have no evidence that the
remaining melanocytes convert to FABP-expressing glia
(Supplementary Figure S3A, right) or islet1-expressing neu-
rons (data not shown). This conditional Smarca4 mutant
verifies the causative mutation in Mos6 mice and confirms
an essential role for the Smarca4-encoded protein, BRG1,
in establishing the SOX10-expressing melanoblast lineage.
The requirement for BRG1 in the activation of melanocyte-
specific genes by SOX10
To elucidate the transcriptional mechanisms by which
BRG1 cooperates with SOX10 to establish the melanocyte
lineage, we turned to a previously described fibroblast cell
line that can be induced to express a dominant negative
version of BRG1 under the control of the tetVP16 ac-
tivator, hereafter referred to as dnBRG1 (38). dnBRG1
lacks chromatin remodeling activity due to a mutation in
the ATPase domain and acts as a dominant negative be-
cause it suppresses gene activation events that normally
require SWI/SNF function. By ectopically expressing ei-
ther SOX10 or MITF in B22 cells, we previously found
that SOX10 interacts with BRG1 to promote myelin gene
expression while MITF interacts with BRG1 to promote
melanocyte-specific gene expression (15,27). To determine
the requirement for BRG1 in SOX10-mediated melanocyte-
specific gene expression, we ectopically expressed MITF,
SOX10, or a combination of MITF and SOX10 in B22 cells
and cultured them in the presence or absence of tetracycline.
Western blotting confirmed that MITF, SOX10, or both
MITF and SOX10were expressed regardless of the presence
or absence of tetracycline, while expression of dnBRG1 was
detected only in cells that had been cultured in the absence
of tetracycline (Figure 3A).
Consistent with our previous semi-quantitative data (27),
we found that ectopic expression of MITF in B22 cells that
were cultured in the presence of tetracycline activated ex-
pression of tyrosinase familymembersDct (110-fold),Tyrp1
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Figure 2. Conditional deletion of Smarca4 resulted in a striking reduction
in the numbers of cranial and ventral trunkmelanoblasts at E12.5. (A) The
melanoblast-containing regions labeled 1 (cranial melanoblasts near optic
cup), 2 (anterior trunk at forelimb) and 3 (posterior trunk at hindlimb)
are shown at greater magnification in B, as indicated. (B) Comparison of
melanoblast number, as measured by whole mount in situ hybridization for
MITF (top), Dct (center) and Kit (bottom) shows fewer melanoblasts in
embryos where Smarca4 was conditionally deleted in melanoblasts using
a SOX10-Cre construct (BRG1/) as compared to normal littermates
(WT). (C) Quantification of cells in the eye region from the ISH whole
mounts that were positive for the indicated melanocyte markers (***P <
0.001, **P < 0.01, Student’s t test).
(600-fold) andTyr (20-fold) and removal of tetracycline and
expression of dominant negative BRG1 dramatically inhib-
ited expression of these three genes (Figure 3B). SOX10
is known to induce Mitf expression when partnered with
PAX3 (50).We found that in the absence of Pax3, ectopic ex-
pression of SOX10 increasedMitf expression <2-fold com-
pared to a control empty vector (data not shown). Interest-
ingly, SOX10 induced expression of MITF target genes to a
greater extent (Figure 3B).Dct was activated by SOX10 (57
000-fold) which was greater than Dct activation by MITF.
However, SOX10 was less effective thanMITF in activating
Tyrp1 (100 fold) and Tyr (5-fold). Co-expression of MITF
and SOX10 resulted in a synergistic increase in Dct expres-
sion (300 000-fold), Tyrp1 (2000-fold) and Tyr (350-fold).
Activation of these three genes by MITF, SOX10 or MITF
in combination with SOX10 was dramatically inhibited by
expression of dnBRG1. These data suggest that BRG1 func-
tionally interacts with SOX10 and that its catalytic activ-
ity is required for expression of the MITF- and SOX10-
regulated genes that encode enzymes involved in melanin
synthesis.
We also investigated whether SOX10 could activate the
expression of two other MITF target genes that are impor-
tant for melanocyte function. The transient receptor po-
tential cation channel member 1 (Trpm1), associated with
terminal melanocyte differentiation, and the small GT-
Pase, Rab27a, which regulates melanosome transport are
known MITF target genes (51–53). We found that MITF
induced Trpm1 (200-fold) andRab27a (80-fold) in a BRG1-
dependent manner (Figure 3C). However, the expression of
these genes did not change significantly in SOX10 express-
ing cells relative to control. The combination of MITF and
SOX10 increased the mRNA levels of Trpm1 and Rab27a
to a small extent (1.6- and 1.25-fold respectively) compared
to the levels induced by MITF alone. Thus, expression
of Trpm1 and Rab27a is highly dependent on MITF and
BRG1 but less so on SOX10 in these cells.
Our previous work had indicated that ectopic expression
of SOX10 in B22 cells can induce expression of Schwann
cell genes that encode myelin protein zero (Mpz) andmyelin
basic protein (Mbp) (15). These genes were recently found
to be regulated by MITF in melanoma cells (54,55). There-
fore, we queried whether SOX10 synergizes with MITF to
increase expression ofMpz andMbp in a BRG1-dependent
manner. We found that MITF alone did not significantly
induce either Mpz or Mbp (Figure 3D). As we determined
previously, SOX10 activated bothMpz andMbp when cells
were cultured in the presence of tetracycline but not when
expression of dnBRG1was induced by the removal of tetra-
cycline. Interestingly, co-expression of MITF with SOX10
prevented SOX10 from inducing these myelin genes. Thus,
in this cellular context, SOX10 cooperates with MITF to
activate a subset of melanocyte-specific genes in a BRG1-
dependent manner but works antagonistically with MITF
to regulate genes important for myelination.
Temporal analysis of melanin synthesis and gene expression
in differentiating melanoblasts
In vitro models of muscle and adipocyte differentiation,
such as C2C12 myoblasts and 3T3L1 pre-adipocytes, have
provided a wealth of knowledge regarding the mecha-
nisms by which previously silent genes embedded in re-
pressive chromatin structure are activated in a lineage-
specific manner (25,56–58). However, in vitro models of
melanocyte differentiation have been rarely used for such
purposes. Therefore, we characterized mouse Melb-a cells,
which are immortalized mouse melanoblasts derived from
black nonagouti mice (39,59), to elucidate the mecha-
nisms by which BRG1 co-activates SOX10 target genes in
melanocytes. These cells can be maintained in an undiffer-
entiated proliferative state when cultured in growthmedium
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Figure 3. Dominant negative BRG1 inhibits activation of melanocyte-specific genes by MITF and SOX10. (A) B22 cells were infected with a pBABE
control vector, pBABE-MITF, pBABE-SOX10 or pBABE-MITF with pBABE-SOX10 in the presence (dominant negative BRG1 off) or absence of tetra-
cycline (dominant negative BRG1 on) and then cultured in low serum medium to promote differentiation. Western Blot analysis showing expression of
MITF and SOX10 in cells that were cultured in the presence and absence of tetracycline, and the expression of FLAG-tagged dominant BRG1 when cells
were cultured in the absence of tetracycline. Protein expression was detected from cell extracts and tubulin was used as a loading control. (B–D) Quanti-
tative RT-PCR (qRT-PCR) of MITF and/or SOX10 target genes from cells transfected with pBABE, pBABE-MITF, pBABE-SOX10 or pBABE-MITF
together with pBABE-SOX10 in the presence or absence of tetracycline demonstrated that dominant negative BRG1 blocked the (B) synergistic activation
ofDct, Tyrp1 and Tyr gene expression by SOX10 andMITF, (C) activation of Trpm1 andRab27a byMITF and (D) activation ofMpz andMbp by SOX10.
Expression of each gene was normalized to expression of Rpl7. The data are the average of at least two independent experiments performed in triplicate.
Standard error bars and statistical significance are shown (**P < 0.01, *P < 0.05, ANOVA).
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containing stem cell factor (SCF) and fibroblast growth
factor 2 (FGF2) and then differentiated into pigmented
melanocytes by shifting sub-confluent cells to differenti-
ation medium containing a stable analog of alpha-MSH
(NDP--MSH). We observed a time-dependent increase in
melanin accumulation when Melb-a cells were shifted from
growth to differentiation medium (Figure 4A). MITF ex-
pression was strongly induced concomitantly with the ob-
served increase in melanin synthesis while SOX10 levels and
BRG1 levels remained constant (Figure 4B). Interestingly,
therewas a small increase in the expression of the alternative
ATPase BRM after 24 h of differentiation, suggesting that
BRMmay have a role in melanocyte differentiation (Figure
4B).
We performed a temporal analysis of gene expression
to determine if genes required for melanin synthesis are
induced during the differentiation process. Our data indi-
cate that expression of these genes increases over a 48-h
time period (Figure 4C and D). This long time-course of
gene induction is likely due to asynchronous differentiation
of individual cells as was previously demonstrated for B16
melanoma cells (60). Induction ofDct andTyrp1 expression
occurred 12 h after shifting to differentiation medium and
peaked after 24 h with a 7–8-fold induction of Dct and 50–
60-fold induction of Tyrp1, while Tyr expression was first
detected at 24 h but increased substantially after 48 h with
an ∼120-fold induction (Figure 4C). Rab27a and Trpm1
were induced with similar kinetics as Dct and Tyrp1, with a
maximum induction of 8-fold and 50-fold respectively (Fig-
ure 4D). Whereas these MITF-dependent genes were con-
sistently induced during the time course of Melb-a differen-
tiation, the expression of Mpz, a gene which was activated
by SOX10 but repressed by MITF in B22 cells, decreased
during the time course of Melb-a differentiation whileMbp
levels fluctuated and exhibited a slight increase of 1.5-fold
after 48 h (Figure 4E).
Temporal analysis of gene expression and chromatin accessi-
bility in differentiating melanoblasts
We performed a temporal analysis of chromatin accessi-
bility in differentiating Melb-a cells to determine if the
observed changes in melanocyte-specific gene expression
were associated with alterations in chromatin structure. The
FAIRE (Formaldehyde-Assisted Isolation of Regulatory
Elements) assay enriches for accessible chromatin sites that
correspond closely withDNase I hypersensitive sites, occur-
ring at transcriptional start sites, promoters, and enhancers
(61). We assayed the regions of Dct, Tyrp1 and Tyr that
contain SOX10 and MITF binding sites: SOX10 binding
sites are located in distal enhancers, while M boxes which
bindMITF are located in proximal promoter regions and E
boxes that also bind MITF are also contained within distal
enhancers (50,62–65). We detected significant FAIRE en-
richment of theDct distal enhancer and proximal promoter
both in undifferentiated and in differentiated Melb-a cells
but not in myoblasts (C2C12) nor pre-adipocytes (3T3L1).
(Figure 5A). There was only a small increase in the FAIRE
enrichment of the distal enhancer after 48 h of differenti-
ation while enrichment of the Dct proximal promoter in-
creased ∼2-fold. The enrichment level of the Tyrp1 distal
enhancer was also high in undifferentiated Melb-a cells but
not in C2C12 or 3T3L1 cells and increased slightly during
the time course of differentiation, whereas there was a sig-
nificant increase in the enrichment level of the Tyrp1 prox-
imal promoter during the time course of differentiation (3-
fold) (Figure 5B). We digested nuclei with MNase I and
confirmed that FAIRE enrichment levels of theTyrp1 distal
and proximal regions reflect changes in chromatin accessi-
bility (data not shown). Similarly, enrichment of theTyr dis-
tal enhancer was high in undifferentiatedMelb-a cells com-
pared to C2C12 and 3T3LI cells and increased to a small
extent during differentiation, while enrichment of the Tyr
proximal promoter was only slightly higher in undifferen-
tiated Melb-a cells than in C2C12 and 3T3L1 cells and in-
creased greatly (7-fold) during the time course of differenti-
ation (Figure 5C). Thus, the distal enhancers of Dct, Tyrp1
and Tyr were observed to be in a constitutively open chro-
matin state prior to differentiation while the chromatin at
the proximal promoters of the highly inducedTyrp1 andTyr
became increasingly accessible upon differentiation. As a
control for FAIRE specificity, we probed a distal regulatory
region (CER) of MyoD, a muscle-specific gene that is ex-
pressed in proliferating C2C12myoblasts (49). As expected,
we found high FAIRE enrichment of this region in C2C12
cells compared toMelb-a and 3T3L1 cells (Figure 5D)while
the level of FAIRE enrichment of the control Scn2a1 up-
stream region was similarly low in all cells (Figure 5E).
We confirmed FAIRE analysis with chromatin immuno-
precipitations (ChIPs) to detect histone modifications that
are associatedwith active gene expression. Active enhancers
are marked by high levels of histone H3 acetylated on lysine
27 (H3K27ac) and low levels of histone H3 trimethylated
on lysine 4 (H3K4me3), while active promoters are marked
by high levels of H3K4me3 and variable levels of H3K27ac
(66). We found that the distal enhancers of Dct, Tyrp1 and
Tyr had low levels of H3K4me3 and high levels of H3K27ac
which did not significantly increase (Dct, Figure 6A, left)
or increased to a small extent upon differentiation (Tyrp1,
Figure 6B, left, Tyr, Figure 6C, left). The proximal promot-
ers of Dct, Tyrp1 and, Tyr displayed variable increases in
both H3K27ac and H3K4me3 enrichment upon differenti-
ation, with Tyr characterized by the lowest relative levels of
these histone modifications in undifferentiated Melb-a cells
and the highest relative increase upon differentiation (Fig-
ure 6A, B, C, right). ChIP specificity was demonstrated by
low enrichment of melanocyte-specific regulatory regions
and highH3K27ac enrichment of theMyoDCER inC2C12
cells (Figure 6D) and low enrichment of the Scn2a1 locus
in all cells (Figure 6E). These experiments confirm FAIRE
analysis which suggests that the distal regulatory regions
of melanocyte-specific genes are primed by open chromatin
structure in undifferentiated melanoblasts, while proximal
promoters become increasingly accessible upon differentia-
tion.
Depletion of SOX10 and BRG1 inhibits melanocyte differen-
tiation and melanocyte-specific gene expression
To investigate the requirement for SOX10 and BRG1 in
Melb-a differentiation, we depleted expression of these pro-
teins by transiently transfecting short interfering RNAs
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Figure 4. Melanin synthesis and changes in gene expression during a time course of melanoblast differentiation (A) Melb-a cells were cultured in growth
medium containing SCF and FGF until 70% confluent (time 0), then growth medium was replaced with differentiation medium containing NDP--MSH
and the cells were cultured for the indicated periods of time. Cells were harvested at each time point and photographed. Cells were counted and an equal
number were subjected to the melanin assay. The data are the average of at least two independent experiments performed in triplicate. Standard error bars
and statistical significance compared to siC are shown (**P < 0.01, *P < 0.05, Student’s t test). (B) Protein extracts were prepared from differentiating
Melb-a cells and subjected to Western blotting with the indicated antibodies. Tubulin was used as a loading control. (C–E) RNA was isolated at the
indicated time points, reversed transcribed and the specific transcript of interest quantified by qRT-PCR. The CT value for each gene was normalized to
Rpl7. The data are the average of at least two independent experiments performed in triplicate. (C) Melanogenic enzyme gene expression increased as the
cells differentiated. (D) Expression of genes associated with melanocyte differentiation increased as the cells differentiated. (E) Expression of myelin genes
either decreased (Mpz) or exhibited a transient modest increase (Mbp). Standard error bars and statistical significance compared to siC are shown (**P <
0.01, *P < 0.05, Student’s t test).
(siRNA). Because SOX10 regulates MITF expression, we
also knocked down MITF to compare the effects of con-
current depletion of SOX10 and MITF with depletion
of MITF alone. Furthermore, because our previous data
in melanoma cells suggested that the alternative ATPase,
BRM, can partially compensate for BRG1 loss (28), we uti-
lized an siRNA sequence that targets only BRG1 and an
siRNA sequence that targets both BRG1 and BRM. These
siRNAs or a non-targeting siRNA (siC) were transfected
into undifferentiatedMelb-a cells and then cells were shifted
to differentiation medium 48 h later. The extent of knock-
downwas evaluated byWestern blotting (Figure 7A and B).
Knockdown of SOX10, BRG1 or BRG1/BRM inhibited
MITF expression in Melb-a cells and knockdown of BRG1
or BRG1/BRM also caused a small decrease in SOX10 ex-
pression (Figure 7A). These results are consistent with other
reports that SOX10 transcriptionally activates MITF ex-
pression (67) and that BRG1 can also contribute to the regu-
lation ofMITF and SOX10 inmelanoma (68) and Schwann
cells (69) respectively. However, it is important to note that
the effect of BRG1 or BRG1/BRMdepletion on the expres-
sion of either MITF or SOX10 was small compared to the
effects seen by depletion with siMITF or siSOX10.
We then assayed the effects of the knockdowns on
melanin content (Figure 7B). Transfection with siSOX10,
which not only depleted SOX10 but also severely inhibited
MITF expression, had a slightly greater effect on observable
pigmentation than transfection of siMITF which depleted
MITF but did not affect SOX10 expression. Depletion of
both BRG1 and BRM had a greater effect on observable
pigmentation compared to depletion of BRG1 alone, sug-
gesting that BRMmay contribute to activation of genes re-
quired for melanin synthesis.
To more precisely determine the relative contributions of
BRG1 and BRM in promoting pigmentation and melanin
synthesis, we utilized additional siRNAs that uniquely
target each of the ATPases. Two siRNAs against BRG1
(siBRG1-II3.1 and siBRG1-II3.3) and two siRNAs directed
against BRM (siBRM-I13.2) and siBRM-I13.3) depleted
the respective proteins with varying efficiencies (Figure 7C).
Depletion of BRG1 by either siBRG1-I13.1 or siBRG1-
I13.3 reducedMITF, TYRP1 and TYR at the protein level,
but had only a slight effect on SOX10 expression, while de-
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Figure 5. Time course of chromatin accessibility at distal and proximal control regions of melanogenic enzyme genes duringMelb-a differentiation. (A–C)
Melb-a cells were cultured in growth medium containing SCF and FGF2 until 70% confluent (time 0). Growth medium was replaced with differentiation
medium containing NDP--MSH and the cells were cultured for the indicated periods of time. C2C12 and 3T3L1 cells were cultured in growth media and
harvested at 70% confluency. Cells were cross-linked and subjected to FAIRE analysis. Enrichment was quantified by qPCR by normalizing to an input
(UnFAIRE) control for each primer set. A schematic of the distal enhancer and proximal promoter elements for each locus is shown above each graph.
(A) Dct, (B) Tyrp1, (C) Tyr. (D) MyoD, (E) Scn2a1 (M: Mbox, S: SOX10 binding site, E: E box). The data are the average of at least two independent
experiments performed in triplicate. Standard error bars and statistically significant differences compared to undifferentiated (0hr) Melb-a cells are shown
(**P < 0.01, *P < 0.05, Student’s t test).
pletion of BRM by either siRNA had minimal effects on
MITF and SOX10. Only the more efficient siBRM-I13.3
substantially reduced TYRP1 and TYR expression at the
protein level. Depletion of BRG1 by either siRNA reduced
observable pigmentation and melanin content while only
the more efficient siRNA targeting BRM had an inhibitory
effect on observable pigmentation and on melanin content
(Figure 7D).
We next investigated the effects of the knockdowns on
expression of SOX10 and MITF target genes. As expected,
knockdown of either SOX10 or MITF inhibited expression
of genes that regulate melanin synthesis and melanocyte
function (Figure 7E and F). Knockdown of BRG1 by ei-
ther siBRG1-D (60% knockdown by qRT-PCR, data not
shown) or siBRG1-I13.1 (80% knockdown by qRT-PCR,
data not shown) significantly reduced expression of these
genes such that the more efficient knockdown of BRG1 re-
sulted in a greater effect onmelanocyte-specific gene expres-
sion (Figure 7E and F). Knockdown of BRM alone by ei-
ther siBRM-I13.2 (65% knockdown by qRT-PCR, data not
shown) or siBRM-I13.3 (80% knockdown by qRT-PCR) re-
sulted in small but significant effects on most melanocyte-
specific genes. Therefore, both BRG1 and BRM likely con-
tribute to the regulation of these melanocyte-specific genes,
with BRG1 depletion having a more severe effect on expres-
sion ofDCT, TYRP1 andTYRat both the protein and gene
levels as well as on observable pigmentation.
Consistent with the inhibitory effect of MITF expression
onMpz andMbp expression in NIH 3T3 cells (Figure 3D),
we found that knockdown of MITF in Melb-a cells led to
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Figure 6. Changes in histone modifications at distal and proximal control regions of melanogenic enzyme genes during Melb-a differentiation. Chromatin
immunoprecipitations (ChIPs) were performed with an antibodies to histone H3, histone H3 acetylated on lysine 27 (H3K27ac), histone H3 trimethylated
at lysine 4 (H3K4me3). or a control IgG antibody. Enrichment was quantified by qPCR by normalizing to H3 for each primer set. ChIP with IgG resulted
in<1% of the enrichment obtained with histone antibodies (data not shown). (A)Dct, (B) Tyrp1, (C)Tyr, (D)MyoDCER, (E) Upstream region of Scn2a1.
The data are the average of at least two independent experiments performed in triplicate. Standard error bars and statistical significance compared to
undifferentiated (0hr) Melb-a cells are shown (**P < 0.01, *P < 0.05, Student’s t test).
an increase in the expression of these genes, while knock-
down of SOX10, BRG1 and BRM decreased their expres-
sion (Figure 7G). Ectopic expression of MITF in SOX10-
depleted cells partially restored Dct, Tyrp1, Tyr and Trpm1
expression and fully restored Rab27a levels to those in cells
expressing control siRNA (siC), but did not have a signifi-
cant effect on the expression ofMpz andMbp (Figure 7H).
These data show that MITF cannot fully compensate for
SOX10 loss in the regulation of a subset of melanocyte-
specific genes that require BRG1, including Dct, Tyrp1 and
Tyr. This suggests that the requirement for SOX10 in the
transcriptional regulation of these genes extends beyond ac-
tivation of MITF expression.
SOX10 and BRG1 promote chromatin accessibility at com-
mon sites in the regulatory regions of co-regulated genes
To determine whether SOX10 and BRG1 are both required
to promote chromatin accessibility at SOX10 binding sites
in the distal enhancers ofDct,Tyrp1 andTyr, we transfected
undifferentiated Melb-a cells with the respective siRNAs
for 48 h, then shifted the cells to differentiation medium
and performedFAIRE (Figure 8A–C). SOX10 depletion re-
duced chromatin accessibility at both the distal and proxi-
mal regulatory regions of Dct and the distal enhancer of
Tyrp1 to levels that were significantly below what was ob-
served in undifferentiated Melb-a cells and reduced chro-
matin accessibility at proximal promoters as well as the Tyr
distal enhancer to levels significantly lower than in control
differentiated cells. Since SOX10 regulates MITF expres-
sion and the proximal promoters have M boxes while the
distal regions have E boxes that potentially bind MITF, we
knocked downMITF to determine if the changes in accessi-
bility that were observed in SOX10 knockdown cells might
be indirectly due to loss of MITF. Depletion of MITF re-
duced chromatin accessibility at both the distal and proxi-
mal regulatory regions to levels that were significantly below
those in control differentiated cells, bringing levels down to
the levels in undifferentiated cells. Importantly, chromatin
accessibility at the Dct and Tyrp1 distal enhancers was sig-
nificantly lower in SOX10 depleted cells than in MITF de-
pleted cells. Knockdown of BRG1also decreased accessibil-
ity at both the distal and proximal regions of Dct, Tyrp1
and Tyr while knockdown of BRM slightly reduced chro-
matin accessibility at the distal and proximal promoters of
Tyrp1 and Tyr but had no effect on either region ofDct. Im-
portantly, depletion of BRG1 resulted in reduced chromatin
accessibility at all regulatory regions examined compared to
depletion of BRM. These data suggest that SOX10 likely
has a role in regulating chromatin structure at distal en-
hancers of some melanocyte-specific genes that extends be-
yond its role in regulatingMITF expression and that BRG1
is the primary SWI/SNF ATPase that regulates chromatin
accessibility at these sites.
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Figure 7. SOX10 and BRG1 are required for melanocyte differentiation. Undifferentiated Melb-a cells were transfected with the indicated siRNAs for 48
hours. The medium was then replaced by differentiation medium and cells were cultured for an additional 48 h. (A) Melb-a cells were subjected to Western
blotting with antibodies to BRG1, BRM,MITF and SOX10. Tubulin was used as a loading control. (B) Melb-a cells transfected with the indicated siRNAs
were pelleted and photographed. Cells were counted, and an equal number were subjected to the melanin assay. Each of the siRNAs resulted in a significant
reduction in melanin relative to the siC. (C) Melb-a cells transfected with siRNAs that uniquely target BRG1 or BRMwere subjected toWestern blotting as
in (A). Protein extracts were also evaluated for TYRP1 and TYR expression. (D) Melb-a cells transfected with siRNAs that uniquely target BRG1 or BRM
were pelleted, photographed and subjected to the melanin assay as in (B). (E–G) RNAwas isolated from siC, siMITF, siSOX10, siBRG1-D, siBRG1-I13.1,
siBRM-I13.2 and siBRM-I13.3 transfected Melb-a cells, reversed transcribed and quantified by qRT-PCR. The CT value for each gene was normalized to
Rpl7. (E) Melanogenic enzyme gene expression. (F) Expression of genes associated with melanocyte differentiation. (G) Expression of myelin genes. The
data are the average of at least two independent experiments performed in triplicate. Standard error bars and statistical significance compared to siC are
shown (**P< 0.01, *P< 0.05, Student’s t test). (H) Melb-a cells were co-transfected with siSOX10 and CMV-MITF. RNAwas isolated from siC, siSOX10,
and siSOX10/CMV-MITF transfected Melb-a cells, reversed transcribed and quantified by qRT-PCR. The CT values for each gene were normalized to
Rpl7 and are presented relative to values obtained with siC transfected cells. The data are the average of at least two independent experiments performed
in triplicate. Standard error bars are shown. Stars indicate statistical difference between the MITF rescued siSOX10 cells compared to siSOX10 (**P <
0.01, *P < 0.05).
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SOX10 physically interacts with BRG1 and recruits BRG1 to
the Tyrp1 enhancer in Melb-a cells
We performed co-immunoprecipitations to detect physical
interactions between SOX10 nd BRG1 in Melb-a cells. Us-
ing an antibody to pull down SOX10, we detected SOX10-
BRG1 as well as SOX10-BRM complexes in both undiffer-
entiated and differentiated Melb-a cells (Figure 9A, left).
We also probed for the BAF60A subunit of the SWI/SNF
complex which was previously shown to interact directly
with SOX10 and promote BRG1recruitment to Schwann
cell-specific loci (14). As in Schwann cells, we detected a
stronger interaction between SOX10 and BAF60A com-
pared to a different subunit, BAF60B. This is consistent
with the previous study that BAF60A mediates SOX10-
SWI/SNF interactions and suggests that BRG1/BRM in-
teract indirectly with SOX10 in melanocytes. Reciprocal co-
immunopreciptations using antibodies to BRG1 or BRM
confirmed that SOX10 interacts with both BRG1 and
BRM. We also probed for MITF and found that although
BRG1-MITF as well as BRM-MITF complexes can be
detected in undifferentiated cells, there is an increase in
these complexes upon differentiation whenMITF levels are
higher (Figure 9A, right). These results show that SOX10 in-
teracts with SWI/SNF complexes in both undifferentiated
melanoblasts and in differentiated melanocytes andmay fa-
cilitate SWI/SNF recruitment to distal regulatory regions
ofmelanogenic enzyme genes where SOX10 has amore pro-
nounced role in chromatin remodeling.
Since chromatin at distal enhancers was found to be ac-
cessible in both undifferentiated and differentiated Melb-a
cells and to be highly affected by knockdown of SOX10 but
less so by MITF knockdown, we hypothesized that SOX10
recruits BRG1 to this site in order to remodel chromatin.
The Tyrp1 proximal region contains an M box which is the
consensus binding site for MITF, and the distal region con-
tains E boxes that potentially bind MITF. We found that
there was little enrichment of MITF at either of these sites
in undifferentiated Melb-a cells and that MITF became as-
sociated with both these sites 12 h after differentiation but
that enrichment ofMITF at the proximal region was higher
than at the distal region (Figure 9B). SOX10 was consti-
tutively enriched at the Tyrp1 distal region in both undif-
ferentiated and differentiated cells while a small but sig-
nificant level of SOX10 enrichment occurred at the proxi-
mal region beginning 12 h after differentiation (Figure 9C).
The significance of SOX10 enrichment at the proximal pro-
moter regions is not clear since this region does not con-
tain SOX10 binding sites. It may reflect non-specific binding
which has been demonstrated by many transcription fac-
tors, including the SOX family member, SOX2, or it may
reflect long range promoter-enhancer interactions, brought
about by chromatin looping (70–72). Like SOX10, BRG1
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Figure 9. SOX10 physically interacts with BRG1 and recruits BRG1 to a melanocyte-specific enhancer in Melb-a cells. (A) Growing Melb-a cells or cells
that had been differentiated for 18 h and either immunoprecipitated with an irrelevant antibody (IgG) or with an antibody to SOX10 (left), antiserum to
BRG1 (top, right), or BRM (bottom, right). Cell extract (CE) or the immunoprecipitated material was run on an SDS-polyacrylamide gel and blotted
with the indicated antibodies. (B) Chromatin immunoprecipitations (ChIPs) were performed with an antibody toMITF or control IgG. Enrichment of the
Tyrp1 distal and proximal regions was quantified by qPCR by normalizing to the IgG control for each primer set and to the Scn2a1 region as a negative
control region. The data are the average of at least two independent experiments performed in triplicate. Standard error bars and statistical significance
compared to undifferentiated cells (0 h) are shown (**P< 0.01, *P< 0.05, Student’s t test). (C) ChIP was performed and analyzed as in B using an antibody
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(0 h) and differentiated (48 h) cells are shown (**P < 0.01, *P < 0.05, ANOVA).
was found to be constitutively associated with the Tyrp1
distal enhancer in both undifferentiated and differentiated
Melb-a cells while recruitment to the Tyrp1 proximal pro-
moter increased during differentiation (Figure 9D). BRG1
recruitment to both these regions was decreased by deple-
tion of either MITF or SOX10, with SOX10 depletion hav-
ing a slightly greater effect on BRG1 recruitment to the dis-
tal enhancer than MITF depletion (Figure 9D). BRM also
constitutively occupied the Tyrp1 distal enhancer in both
undifferentiated and differentiated cells, while recruitment
to the proximal promoter increased upon differentiation
and in anMITF- and SOX10-dependent manner. However,
enrichment of BRM at the distal enhancer was substan-
tially less than that of BRG1 (Figure 9E). In combination,
these data suggest SOX10 facilitates recruitment of BRG1
to distal enhancers. Thus, BRG1 is a SOX10 co-activator,
required to establish the melanocyte lineage and promote
expression of genes important for melanocyte function.
DISCUSSION
SOX10 interacts with a diverse set of transcriptional reg-
ulators to promote development of multiple cell lineages
and is essential for the survival and differentiation of neural
crest-derived melanocytes and Schwann cells (7,8). As ‘ar-
chitectural transcription factors,’ SOX proteins were origi-
nally thought exert their effects on transcription by virtue
of their ability to bend DNA (73). However, activation of
transcription by SOX10 has recently been associated with
recruitment of chromatin remodeling enzymes to regula-
tory regions (14,15). SOX10 was found to genetically and
functionally interact with Smarca4, the gene encoding the
BRG1 component of the SWI/SNF chromatin remodeling
complex, to activate Schwann cell-specific gene expression
at multiple steps in Schwann cell differentiation (14,15).
BRG1-deficient mice exhibit Schwann cell defects strikingly
similar to those seen in SOX10-deficient mice and these
defects are exacerbated by additional heterozygous loss of
one SOX10 allele in BRG1-deficient mice. Our studies re-
veal that SOX10 also interacts genetically and functionally
with BRG1 to promote melanocyte development. Utiliz-
ing an ENU-based mutagenesis screen, we found that het-
erozygous mutations in Smarca4 exacerbate the spotting
phenotype exhibited by SOX10 haploinsufficient mice, re-
sulting in severe hypopigmentation. This is strong evidence
that SOX10 and BRG1 act together in the melanocyte lin-
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eage. In contrast, a genetic interaction between SOX10 and
BRG1 was not observed during oligodendrocyte differen-
tiation, despite a requirement for both SOX10 and BRG1
in this process (74). Instead, the requirement for BRG1 in
oligodendrocyte differentiation may occur at a stage prior
to when SOX10 is required. Thus, the observed interactions
between SOX10 and BRG1 in melanocytes and Schwann
cells may not be essential for differentiation of all cell types
that express these proteins.
To confirm that disruption of BRG1 function was re-
sponsible for the observed hypopigmentation phenotype,
we deleted Smarca4 using a SOX10-Cre construct (33,34).
Conditional deletion of Smarca4 resulted in a striking loss
of cranial and trunk melanoblasts (Figure 2). The observed
loss of melanocytes is consistent with a previous study that
utilized a Tyr-Cre construct to delete Smarca4 (29), and
confirms that BRG1 is required to establish the melanocyte
lineage in vivo. It was previously unclear what happens to
themelanocyte lineagewhenBRG1 is deleted.We now show
that loss of BRG1 does not result in trans-differentiation to
other neural crest lineages. Therefore, it is likely that loss of
BRG1, like SOX10 and MITF, compromises melanoblast
survival during embryonic development.
These results suggest that the alternative SWI/SNF AT-
Pase, BRM, cannot compensate for the loss of BRG1 in the
embryonic development of the melanocyte lineage. An ab-
solute requirement for BRG1 and lack of compensation by
BRM has been demonstrated in several other lineages in-
cluding muscle (14,75–77). Indeed, our in vitro studies con-
firm that knockdown of BRG1 has a more profound effect
on pigmentation, melanocyte-specific gene expression, and
chromatin remodeling at several melanocyte-specific loci,
than knockdown of the alternative ATPase, BRM. How-
ever, our data also show that BRM can interact with both
SOX10 and MITF and be recruited to the regulatory re-
gions of melanocyte-specific genes. It was previously shown
that although BRM cannot compensate for BRG1 loss dur-
ing embryonic development of vascular endothelial cells,
BRM can compensate for BRG1 in maintaining these cells
in the adult mouse heart (78). BRM null mice also dis-
play defects in muscle regeneration and BRM was found
to be distinctly required for cell cycle arrest and late muscle
specific gene expression (79). Our observations as well as
other reports that associated BRM with highly differenti-
ated cells (80) as well as melanocyte senescence (81) suggest
that although BRM cannot compensate for BRG1 in early
stages of melanocyte development, BRMmay be important
at later stages ofmelanocyte development or formelanocyte
maintenance.
We found that SOX10 and BRG1 physically and func-
tionally interact to promote melanocyte differentiation in
cultured cells. The requirement for BRG1 in the melanocyte
lineage has previously been attributed primarily to physi-
cal and functional interactions with MITF, which serve to
recruit BRG1 to target genes involved in melanocyte dif-
ferentiation, proliferation, and survival (28–29,41). How-
ever, BRG1 had also been reported to regulate MITF ex-
pression, to promote melanoma survival throughMITF in-
dependent mechanisms, and to co-occupy SOX10 binding
sites in melanoma cells (29,68,82). Establishing a functional
interaction between SOX10 and BRG1 in melanocytes and
melanoma cells has been complicated because melanocyte
genes are co-regulated by SOX10 and MITF, including
MITF itself. Therefore, knockdown of SOX10 results in
depletion of MITF, which then abrogates BRG1 recruit-
ment. Our findings suggests that SOX10 facilitates recruit-
ment of BRG1 to the Tyrp1 distal enhancer. We found that
SOX10 physically interacts with BRG1 in undifferentiated
melanoblasts that express very low levels of MITF and that
exhibit constitutively open chromatin structure at distal en-
hancers containing SOX10 binding sites. Furthermore, the
timing of SOX10 and BRG1 binding to the Tyrp1 distal
enhancer coincide in undifferentiated melanoblasts, occur-
ring when MITF binding to this region is very low. How-
ever, both SOX10 andMITFdepletion compromisedBRG1
recruitment to the Tyrp1 distal enhancer, suggesting that
SOX10 and MITF cooperate to recruit BRG1. In combi-
nation, these data suggest that in melanocyte precursors,
SOX10 marks some melanocyte genes for later activation
by MITF in part by recruiting BRG1 to distal enhancers.
In summary, we provide evidence that BRG1 is required
for establishment of the melanocyte lineage in vivo and
closely correlate this function with the role of SOX10 dur-
ing melanocyte development. Our in vitro studies show
that BRG1 is also required for melanin synthesis during
melanocyte differentiation.
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